Atara BiotherapeuticsATRA
13F holders, Q4 2024 (December 31)2holders +1
0new positions
0sold out
$13.32avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Atara Biotherapeutics Inc. (ATRA) in their 13F filings, up 1 from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were EverSource Wealth Advisors, LLC ($466) and Alexis Investment Partners, LLC ($373).
- Company
- Atara Biotherapeutics Inc.
- CUSIP
- 046513107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| EverSource Wealth Advisors, LLC | 0.00% | No change | 35 | $466 |
| Alexis Investment Partners, LLC | 0.00% | — | 28 | $373 |
"% of holder's portfolio" is ATRA's weight in each manager's 13F, not the share of Atara Biotherapeutics Inc. the manager owns.